Kaiphal (Myrica nagi): A Botanical Origin Drug (Dawa) of Unani Medicine for Prevention and Treatment of Common Disorders
Abstract
Myrica nagi is a celebrity medicinal plant that is distributed in sub-Himalayan regions and holds several pharmacological actions and therapeutic effects along with their economic usage. In Unani System of Medicine (USM), it is well known, as Kaiphal and used in the prevention and the management of several common disorders viz. Amraz-i-Riya (Respiratory disease), Amraz-i-Hazam (Gastrointestinal disease), Amraz-i-Aasab (Nervine disease), and Amraz-i-Bawl (genitourinary disease). Recent clinical studies evaluate that the Kaiphal consist of numerous phytoconstituents viz. tannins, flavonoids, phenolic acids, terpenes, glycosides, amino acids, steroids, and volatile oils. These phytoconstituents are responsible for varieties of pharmacological actions viz. Anti-inflammatory, Anti-Oxidant, Anti-Allergic, Anti-helminthic, Neuroprotective, Nephroprotective, Anti-hypertensive, Anticancer, and Anxiolytic. Conventionally, different parts of Kaiphal are used in asthma, allergic disorder, inflammatory diseases, neurological disorders, renal disease, and cancer. The physicians of USM described properties and therapeutics uses of Kaiphal but data on safety and efficacy are limited and also lack of attraction of researcher toward a preclinical and clinical trial. Therefore, this review updated the knowledge about pharmacological and therapeutic effects, ethnomedicinal uses, adverse effects, prevention and treatment of common disorders and also focused on future research in the prospective era.
Keyword: Kaiphal, Myrica nagi, USM, Phytoconstituents, Asthma
Downloads
References
Sonowal N, Syndor A, Lapasam P, Boruah A, Sarkar BR, Bhattacharjee A, Dey BK. Evaluation of pharmacognostical parameters and preliminary phytochemical screening of leave of the plant Myrica esculenta. Evaluation. 2018 Jul;3(4):07-12.
Kumar A, Rana AC. Pharmacognostic and pharmacological profile of traditional medicinal plant: Myrica nagi. International research journal of pharmacy. 2012;3(12):32-37.
Sood P, Shri R. A review on ethnomedicinal, phytochemical and pharmacological aspects of Myrica esculenta. Indian Journal of Pharmaceutical Sciences. 2018 Feb 28;80(1):2-13. https://doi.org/10.4172/pharmaceutical-sciences.1000325
Kabra A, Martins N, Sharma R, Kabra R, Baghel US. Myrica esculenta Buch.-Ham. ex D. Don: a natural source for health promotion and disease prevention. Plants. 2019 Jun;8(6):1-21. https://doi.org/10.3390/plants8060149
PMid:31159283 PMCid:PMC6631742
Sharma A, Bhardwaj J. Myrica nagi (Kaphal: A wild fruit of Himalaya). Journal of Medicinal Plants. 2019;7(1):30-2.
Prashar Y, Patel NJ. A review on Myrica nagi approach in recognizing the overall potential of the plant. Res J Life Sci Bioinform Pharm Chem Sci. 2018;4:217-31.
Zaidi IH. A Text Book on Kulliyat-e-Umoor-e-Tabi'yah (Basic principle of Unani Tibb). New Delhi: CCRUM; 2011 Sep. 32-50.
Zaidi IH. Temperamentology a scientific appraisal of human temperament. Aligarh: Dr. I. H. Zaidi; 1999. 12-24.
Hamdani KH. Usool-e-Tib. 3rd ed. New Delhi: quami council Baraye fraog urdu Jaban; 2006. 405-415.
Kabeeruddin HM. Makhzanul Mufradat. New Delhi: Idara Kitab-us-Shifa; 2007:315-16.
Ghani N. Khazain al-Adviya. New Delhi: Idara Kitab-us-Shifa; YNM:113-14
Kabeeruddin HM. Ilmul Advia Nafeesi. New Delhi: Ijaz Publication House; 2007:313-314.
Kabeeruddin H. Makhzanul Mufradat, Al-maruf Khuwas al-advia. New Delhi: Ijaz Publication House; YNM: 435-436.
Multani HDH. Hindustan aur Pakistan Ki Jadibutiya. Lahore: Maktab Daniyal; YNM: 790-91.
Tariq DHNA. Taj al-Mufradat. New Delhi: Ejaz Publication House; 2010:530-531.
Usmani DMI. Tnaqeeh-ul-Mufradat. Delhi: Famous Offset Press; 2008:193-94
Khan MA. Muhit-I Azam. Vol. 4. New Delhi: CCRUM; 2018:533-36.
Qasmi IA. Kitab al-Mufrdat. Aligarh: International Printing Press; 2001:108.
Khan JA. Mufradat-i-Maseehi. New Delhi: National Council for Promotion of Urdu Language; 2012:70.
Ansari MY. Munafe-ul-Mufradat. New Delhi: Ijaz Publication House; 2012: 51-52.
Thakur A, Thakur NS, Kumar P. Preparation of Myrica nagi (Box myrtle) drink and effect of storage temperature on its quality. Journal of Applied and Natural Science. 2017 Dec 1;9(4):2137-42. https://doi.org/10.31018/jans.v9i4.1500
Sharma A, Bhardwaj J. Myrica nagi (Kaphal: A wild fruit of Himalaya). Journal of Medicinal Plants. 2019;7(1):30-32.
Markhap V, Basumatary K, Mazumder AH, Nongrem N. A study on medicinal value of katphala (sohphie - local khasi name) commonly practiced by khasi traditional healer for various ailments: a review with ayurvedic perspectives. IAMJ. Oct 2020;00:4853-57. https://doi.org/10.46607/iamj4608102020
Panthari PR, Kharkwal HA, Kharkwal H, Joshi DD. Myrica nagi: A review on active constituents, biological and therapeutic effects. Int. J. Pharm. Pharm. Sci. 2012;4(Suppl 5):38-42.
Srivastava B, Sharma VC, Pant P, Pandey NK, Jadhav AD. Evaluation for substitution of stem bark with small branches of Myrica esculenta for medicinal use-A comparative phytochemical study. Journal of Ayurveda and integrative medicine. 2016 Oct 1;7(4):218-23. https://doi.org/10.1016/j.jaim.2016.08.004
PMid:27890701 PMCid:PMC5192258
Patel KG, Rao NJ, Gajera VG, Bhatt PA, Patel KV, Gandhi TR. Anti-allergic activity of stem bark of Myrica esculenta Buch.-Ham.(Myricaceae). Journal of Young Pharmacists. 2010 Jan 1;2(1):74-8. https://doi.org/10.4103/0975-1483.62219 PMid:21331196 PMCid:PMC3035891
Patel T, Rajshekar C, Parmar R. Mast cell stabilizing activity of Myrica nagi bark. Journal of Pharmacognosy and Phytotherapy. 2011 Sep 30;3(8):114-7.
Kumar HP, Panda P, Karunakar P, Shiksha K, Singh L, Ramesh N, Usha T, Middha SK. Potential Cyclooxygenase (COX-2) enzyme inhibitors from Myrica nagi-from in-silico to in-vitro investigation. Pharmacognosy Magazine. 2019 Jul 1;15(64):280. https://doi.org/10.4103/pm.pm_56_19
Middha SK, Usha T, Babu D, Misra AK, Lokesh P, Goyal AK. Evaluation of antioxidative, analgesic and anti-inflammatory activities of methanolic extract of Myrica nagi leaves-an animal model approach. Symbiosis. 2016 Jun;70(1):179-84. https://doi.org/10.1007/s13199-016-0422-y
Patel T, Dudhpejiya A, Sheath N. Anti inflammatory activity of Myrica nagi Linn. Bark. Ancient science of life. 2011 Apr;30(4):100.
Agnihotri S, Wakode S, Ali M. Essential oil of Myrica esculenta Buch. Ham.: composition, antimicrobial and topical anti-inflammatory activities. Natural product research. 2012 Dec 1;26(23):2266-9. https://doi.org/10.1080/14786419.2011.652959 PMid:22260222
Mann S, Satpathy G, Gupta RK. In vitro evaluation of bio-protective properties of underutilized Myrica esculenta Buch.-Ham. ex D. Don fruit of Meghalaya. IJNPR. 2015 Sep; 6(3):183-188.
Kabra A, Sharma R, Hano C, Kabra R, Martins N, Baghel US. Phytochemical composition, antioxidant, and antimicrobial attributes of different solvent extracts from myrica esculenta buch.-Ham. ex. D. Don Leaves. Biomolecules. 2019 Aug;9(8):1-15. https://doi.org/10.3390/biom9080357 PMid:31405047 PMCid:PMC6724038
Jain VK, Jain B. Antihelmintic activity of ethanolic extract of bark of Myrica esculenta. International Journal of Pharmaceutical Sciences and Research. 2010 Nov 1;1(11):129.
Nhiem NX, Van Kiem P, Van Minh C, Tai BH, Cuong NX, Thu VK, Anh HL, Jo SH, Jang HD, Kwon YI, Kim YH. A new monoterpenoid glycoside from Myrica esculenta and the inhibition of angiotensin I-converting enzyme. Chemical and Pharmaceutical Bulletin. 2010 Oct 1;58(10):1408-10. https://doi.org/10.1248/cpb.58.1408 PMid:20930414
Khan Y, Sagrawat H, Upmanyu N, Siddique S. Anxiolytic properties of Myrica nagi bark extract. Pharmaceutical Biology. 2008 Jan 1;46(10-11):757-61. https://doi.org/10.1080/13880200802315436
K Rana R, K Patel R. Pharmacological evaluation of antiasthmatic activity of Myrica nagi bark extracts. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 2016 Aug 1;15(2):145-52. https://doi.org/10.2174/1871523015666160923154547 PMid:27666395
Kabra A, Baghel US, Hano C, Martins N, Khalid M, Sharma R. Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson's disease. Journal of Ayurveda and Integrative Medicine. 2020 Oct 1;11(4):448-54. https://doi.org/10.1016/j.jaim.2020.06.007 PMid:32912644 PMCid:PMC7772500
Dua TK, Joardar S, Chakraborty P, Bhowmick S, Saha A, De Feo V, Dewanjee S. Myricitrin, a glycosyloxyflavone in Myrica esculenta bark ameliorates diabetic nephropathy via improving glycemic status, reducing oxidative stress, and suppressing inflammation. Molecules. 2021 Jan;26(2):1-34. https://doi.org/10.3390/molecules26020258 PMid:33419120 PMCid:PMC7825565
Kar P, Chakraborty AK, Dutta S, Bhattacharya M, Chaudhuri TK, Sen A. Fruit juice of silverberry (Elaeagnus) and bayberry (Myrica) may help in combating against kidney dysfunctions. Clinical Phytoscience. 2019 Dec;5(1):1-9. https://doi.org/10.1186/s40816-019-0117-z
Prashar Y, Patel NJ. An in vitro approach to evaluate the anti-adipogenic effect of Myrica nagi Thunb. Fruit extract on 3T3-L1 adipocyte cell line. Obesity Medicine. 2020 Jun 1;18 (2020):1-7. https://doi.org/10.1016/j.obmed.2020.100228
Copyright (c) 2023 KALEEM AHMAD, Mohd Aleemuddin Quamri
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 